Articles By RheumNow
Abatacept Shows Promise for RA-ILD
By RheumNow
Abatacept (Orencia) may be a useful treatment option for patients with rheumatoid arthritis (RA) who develop interstitial lung disease (ILD), a Spanish study suggested.
Read Article
Methotrexate May Help in Chronic Chikungunya Arthritis
By RheumNow
Methotrexate may provide benefits in treatment of the chronic arthritis that can persist following acute chikungunya virus infection, but definitive evidence remains lacking, researchers reported.
Read Article
ESRD Death Declines in Vasculitis Patients
By RheumNow
In the past 2 decades, mortality from end-stage renal disease (ESRD) among U.S. patients with granulomatosis with polyangiitis (GPA) has declined significantly, a nationwide study found.
Read Article
PRESERVE Study: HAQ, BMI and Age Predict Responses to Combo Therapy
By RheumNow
Rheumatoid arthritis patients who were younger and who had lower body mass index, Health Assessment Questionnaire (HAQ) scores, and less disease activity at baseline were most likely to achieve remission after combination etanercept (Enbrel) and methotrexate induction therapy, a post hoc analysis of the PRESERVE trial found.
Read Article
Apremilast’s Rapid Onset in Psoriatic Arthritis
By RheumNow
Monotherapy with apremilast (Otezla) among patients with psoriatic arthritis who were biologic-naive was significantly more effective than placebo as early as week 2 in a phase IIIb study.
Read Article
Stroke Risk Confirmed in SLE
By RheumNow
The most common cerebrovascular events (CVEs) seen among a large cohort of patients with systemic lupus erythematosus (SLE) were stroke and transient ischemia, and the majority of these events were attributable to the disease itself, a multinational study determined.
Read Article
Small Joint Surgeries Drop Among RA Patients
By RheumNow
The rate of small - but not large - joint surgery has dropped among patients with rheumatoid arthritis since 1995, a retrospective review of orthopedic surgeries found. By 2015, less than 1% of patients per year underwent small joint surgery, reported Ashima Makol, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues in Arthritis Care & Research.
Read Article
Stem Cell Transplant Succeeds in Scleroderma
By RheumNow
Myeloablative autologous stem cell transplantation was significantly more effective than 12 months of cyclophosphamide among patients with severe scleroderma, an open-label multicenter study found.
Read Article
MEASURE 3 Study - Anti-IL17 Benefits Persist in Spine Disease
By RheumNow
Patients with ankylosing spondylitis (AS) have shown rapid and sustained responses to secukinumab (Cosentyx) in a third phase III trial that includes a higher dose of this anti-interleukin-17A monoclonal antibody, researchers reported.
Read Article
Fatigue, HAQ and Hand Disability Correlated in Early Systemic Sclerosis
By RheumNow
Early diffuse cutaneous systemic sclerosis (SSc) was associated with high levels of disability and fatigue, according to analysis of data from the European Scleroderma Observational Study cohort.
Read Article